Menstrual health and the metabolic syndrome in adolescents

Annals of the New York Academy of Sciences

Volumn 1135, Issue , 2008, Pages 85-94

  Tfayli, Hala ^a   Arslanian, Silva ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Adolescents; Menstrual cycle; Metabolic syndrome

Indexed keywords

ANDROGEN; DIAZOXIDE; GONADORELIN AGONIST; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; METFORMIN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; TESTOSTERONE; TRIACYLGLYCEROL; TROGLITAZONE;

ABDOMINAL OBESITY; ADOLESCENT; ADOLESCENT DISEASE; ADOLESCENT HEALTH; ADRENARCHE; AMENORRHEA; ANDROGEN SYNTHESIS; ANTHROPOMETRY; BLOOD PRESSURE; BODY MASS; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DYSLIPIDEMIA; FAMILY HISTORY; HORMONE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPOPROTEIN BLOOD LEVEL; MENSTRUATION; MENSTRUATION DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PREPUBERTY; PREVALENCE; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 45549098155     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1429.024     Document Type: Conference Paper

References (71)

1. National Cholesterol Education Program. 2001. Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Full Report. National Institutes of Health. Bethesda, MD. NIH Publication No. 01-3670.
2. Lee, S., N. Gungor, F. Bacha, et al. 2008. Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers. J. Pediatr. 152 : 177 184.
3. Cook, S., P. Auinger, C. Li, et al. 2008. Metabolic syndrome rates in United States adolescents, from the national health and nutrition examination survey, 1999-2002. J. Pediatr. 152 : 165 170.
4. Ehrmann, D., D. Liljenquist, K. Kasza, et al. 2006. Prevalence and predictors of the metabolic syndrome in women with PCOS. J. Clin. Endocrinol. Metab. 91 : 48 53.
5. Coviello, A., R.S. Legro & A. Dunaif. 2006. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J. Clin. Endocrinol. Metab. 91 : 492 497.
6. De Ferranti, S.D., K. Gauvreau, D.S. Ludwig, et al. 2004. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 110 : 2494 2497.
7. Ford, E.S. 2005. Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the US. Diabetes Care 28 : 2745 2749.
8. Lewy, V., K. Danadian, S.F. Witchel, et al. 2001. Early metabolic abnormalities in adolescent girls with polycycstic ovarian syndrome. J. Pediatr. 138 : 38 44.
9. Palmert, M.R., C.M. Gordon, A.I. Kartashov, et al. 2002. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87 : 1017 1023.
10. Reaven, G.M. 1988. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 : 1595 1607.
11. Kahn, R. 2007 Metabolic syndrome: is it a syndrome? Does it matter? Circulation 115 : 1806 1811.
12. Reaven, G. 2006. The metabolic syndrome: is this diagnosis necessary? Am. J. Clin. Nutr. 83 : 1237 1247.
13. Day, C. 2007. Metabolic syndrome, or what you will: definitions and epidemiology. Diabetes Vasc. Dis. Res. 4 : 32 38.
14. Weiss, R., J. Dziura, T.S. Burgert, et al. 2004. Obesity and the metabolic syndrome in children and adolescents. N. Engl. J. Med. 350 : 2362 2374.
15. Cook, S., M. Weitzman, P. Auinger, et al. 2003. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch. Pediatr. Adolesc. Med. 157 : 821 827.
16. Cruz, M., M. Weigensberg, T. Huang, et al. 2004. The metabolic syndrome in overweight hispanic youth and the role of insulin sensitivity. J. Clin. Endocrinol. Metab. 89 : 108 113.
17. Jolliffe, C.J. & I. Janssen. 2007. Development of age-specific adolescent metabolic syndrome criteria that are linked to the Adult Treatment Panel III and International Diabetes Federation Criteria. J. Am. Coll. Cardiol. 49 : 891 898.
18. Zimmet, P., G. Alberti, F. Kaufman, et al. 2007. On behalf of the international diabetes federation task force on epidemiology and prevention of diabetes. Lancet 369 : 2059 2061.
19. Ogden, C.L., M.D. Carroll, L.R. Curtin, et al. 2006. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 : 1549 1555.
20. Li, C., E.S. Ford, A.H. Mokdad, et al. 2006. Recent trends in waist circumference and waist-height ratio among US children and adolescents. Pediatrics 118 : e1390 e1398.
21. Lee, S., F. Bacha & S. Arslanian. 2006. Waist circumference, blood pressure, and lipid components of the metabolic syndrome. J. Pediatr. 149 : 809 816.
22. Lee, S., N. Gungor, F. Bacha, et al. 2007. Insulin resistance link to the components of the metabolic syndrome and biomarkers of endothelial dysfuncrion in youth. Diabetes Care 30 : 2091 2097.
23. Vanhala, M.J., P.T. Vanhala, S.M. Keinanen-Kiukaaniemi, et al. 1999. Relative weight gain and obesity as a child predict metabolic syndrome as an adult. Int. J. Obes. Relat. Metab. Disord. 23 : 656 659.
24. Sun, S., R. Liang, T. Huang, et al. 2008. Childhood obesity predicts adult metabolic syndrome: the Fels longitudinal study. J. Pediatr. 152 : 191 200.
25. Katzmarzyk, P.T., L. Perusse, R.M. Malina, et al. 2001. Stability of indicators of the metabolic syndrome from childhood and adolescence to young adulthood: the Quebec family study. J. Clin. Epidemiol. 54 : 190 195.
26. Morrison, J.A., L.A. Friedman, P. Wang, et al. 2008. Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabtes mellitus 25 to 30 years later. J. Pediatr. 152 : 201 206.
27. Nestler, J.E. 2000. Obesity, insulin, sex steroids and ovulation. Int. J. Obes. Relat. Metab. Disord. 24 (Suppl 2 S71 S73.
28. Ehrmann, D.A., R.B. Barnes, R.L. Rosenfield, et al. 1999. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22 : 141 146.
29. Legro, R.S., A.R. Kunselman, W.C. Dodson, et al. 1999. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J. Clin. Endocrinol. Metab. 84 : 165 169.
30. Dunaif, A., K.R. Segal, W. Futterweit, et al. 1989. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38 : 1165 1174.
31. Apridonidze, T., P.A. Essah, M.J. Iuorno, et al. 2004. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 90 : 1929 1935.
32. Cersosimo, E. & R. DeFronzo. 2006. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab. Res. Rev. 22 : 423 436.
33. Reaven, G. 2005. The inulin resistance syndrome: definition and dietary approaches to treatment. Annu. Rev. Nutr. 25 : 391 406.
34. Kiddy, D.S., D. Hamilton-Fairley, A. Bush, et al. 1992. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin. Endocrinol. 36 : 105 111.
35. Nestler, J.A., C.O. Barlascini, D.W. Matt, et al. 1989. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 68 : 1027 1032.
36. Dunaif, A., D. Scott, D. Finegood, et al. 1996. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 81 : 3299 3306.
37. Ehrmann, D.A., D.J. Schneider, B.E. Sobel, et al. 1997. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J. Clin. Endocrinol. 82 : 2108 2116.
38. Arslanian, S., V. Lewy, K. Danadian, et al. 2002. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticorticotropin with reduction of insulinemia/insulin resistance. J. Clin. Endocrinol. Metab. 87 : 1555 1559.
39. Baillargeon, J.P. & A. Crapentier. 2007. Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. Fert. Steril. 88 : 886 893.
40. Nestler, J.E., D.J. Jakubowicz, A.F. de Vargas, et al. 1998. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositol glycan mediators as the signal transduction system. J. Clin. Endocrinol. Metab. 83 : 2001 2005.
41. Willis, D., H. Mason, C. Gilling-Smith, et al. 1996. Modulation by insulin of follicle-stimulating hormone and luteneizing hormone actions in human granulose cells of normal and polycystic ovaries. J. Clin. Endocrinol. Metab. 81 : 302 309.
42. Burger, H.G. 2002. Androgen production in women. Fertil. Steril. 77 (Suppl 4 S3 S5.
43. Qin, K. & R.L. Rosenfield. 1998. Role of cytochrome P450c17 in polycystic ovary syndrome. Mol. Cell. Endocrinol. 145 : 111 121.
44. Munir, I., H. Yen, D. Geller, et al. 2004. Insulin augmentation of 17α-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells. Endocrinology 145 : 175 183.
45. Dunaif, A. 1997. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Rev. 18 : 774 800.
46. Apter, D., T.L. Butzow, G.A. Laughlin, et al. 1994. Accelerated 24-hour luteneizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism; relevance to the development phase of polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 79 : 119 125.
47. Mehta, R.V., K.S. Patel, M.S. Coffler, et al. 2005. Luteneizing hormone secretion is not influenced by insulin infusion in women with polycystic ovary syndrome despite improved insulin sensitivity during pioglitazone treatment. J. Clin. Endocrinol. Metab. 90 : 2136 2141.
48. Artz, E., et al. 2005. Hormonal and metabolic consequences of childhood obesity. Endocrinol. Metab. Clin. N. Am. 34 : 643 658.
49. Sam, S., A. Dunaif. 2003. Polycystic ovary syndrome: syndrome XX? Trends Endocr. Metabol. 14 : 365 370.
50. Mauras, N., S. Welch, A. Rini, et al. 1998. Ovarian hyperandrogenism is associated with insulin resistance to both peripheral carbohydrate and whole-body protein metabolism in postpubertal young females: a metabolic study. J. Clin. Endocrinol. Metab. 83 : 1900 1905.
51. Arslanian, S., V. Lewy & K. Danadian. 2001. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta cell dysfunction and risk of cardiovascular disease. J. Clin. Endocrinol. Metab. 86 : 66 71.
52. Libman, I. & S.A. Arslanian. 1999. Type II diabetes mellitus; no longer just adults. Pediatr. Ann. 28 : 589 593.
53. Glueck, C.J., J. Morrison, L. Friedman, et al. 2006. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents. Metabol. Cin. Exp. 55 : 508 514.
54. Azziz, R., K.S. Woods, R. Reyna, et al. 2004. The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. 89 : 2745 2749.
55. Wild, R.A. 2002. Polycystic ovary syndrome: a risk for cardiovascular disease? PCOS Am. J. Obstet. Gynecol. 186 : 35 43.
56. Kelly, C.J., A. Speirs, G.W. Gould, et al. 2002. Altered vascular function in young women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87 : 742 746.
57. Paradisi, G., H.O. Steinberg, A. Hempfling, et al. 2001. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 103 : 1410 1415.
58. Legro, R.S. 2003. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr. Rev. 24 : 302 312.
59. Reckelhoff, J.F. 2001. Gender differences in the regulation of blood pressure. Hypertension 37 : 1199 1208.
60. Burt, V.L., P. Whelton, E.J. Roccella, et al. 1995. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25 : 305 313.
61. Mantazaros, C., E. Georgiadis, R. Young, et al. 1995. Relative androgenecity, blood pressure levels and cardiovascular risk factors in young healthy women. Am. J. Hypertens. 8 : 606 614.
62. Chen, M.J., W.S. Yang, J.H. Yang, et al. 2007. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome. Hypertension 49 : 1442 1447.
63. Reckelhoff, J. 2007. Polycystic ovary syndrome: androgens and hypertension [editorial]. Hypertension 49 : 1220 1221.
64. Talbott, E., D. Guzick, A. Clerici, et al. 1995. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscl. Thromb. Vasc. Biol. 14 : 821 826.
65. Robinson, S., A.D. Henderson, S.V. Gelding, et al. 1996. Dyslipidemia is associated with insulin resistance in women with polycystic ovaries. Clin. Endocrinol. 44 : 277 284.
66. Legro, R.S., M.A. Kunselman & A. Dunaif. 2001. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am. J. Med. 111 : 607 613.
67. Wild, R.A., P.C. Painter, P.B. Coulson, et al. 1985. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 61 : 946 951.
68. Bell, R., S. Davison, M.A. Papalia, et al. 2007. Endogenous androgen levels and cardiovascular risk profile in women across the adult life span. Menopause 14 : 630 638.
69. Bataille, V., B. Perret, A. Evans, et al. 2005. Sex hormone binding globulin is a major determinant of the lipid profile: the PRIME study. Atherosclerosis 179 : 369 373.
70. Glueck, C.J., R. Papanna, P. Wang, et al. 2003. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism 90 : 4797 4802.
71. Leibel, N., E. Baumann, M. Kocherginsky, et al. 2006. Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome. Metabolism 91 : 1275 1283.